Cellular Dynamics International, Cellomics, National Center for Drug Screening, Guava Technologies, Strategic Research Institute, Sigma-Aldrich, Invitrogen | GenomeWeb

Cellular Dynamics International Opens Doors

Cellular Dynamics International, a privately held company engaging in cell-based drug screening, has recently begun construction of laboratory facilities at University Research Park in Madison, Wis., the company said last week.

CDI was founded by James Thomson, Craig January, and Timothy Kamp, researchers at the University of Wisconsin-Madison; and Tactics II Ventures LP, a Wisc.-based venture capital firm.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.